Stocks · Healthcare · Biotechnology
Caribou Biosciences, Inc. CRBU
$1.19 -2.46% Close, Oct 5, 2026 · NASDAQ · Market cap $121.0M
Weak trendExpensive vs sectorHigh risk
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -1090.9% from -1837.6% a year earlier.
- The stock is 58% below its highest close of the past year.
- Earnings beat analyst estimates in each of the last 5 quarters (average surprise over the last four: +19.7%).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 47%
- Revenue growth, 3-year CAGRBottom 13%
- Revenue growth accelerationBottom 32%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 13%
- Gross marginBottom 5%
- Operating marginBottom 11%
- Accruals (lower is better)Bottom 44%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 8%
- Free-cash-flow yieldBottom 4%
- EBITDA / enterprise valueBottom 6%
- Sales / enterprise valueBottom 27%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 18%
- 6-month returnBottom 10%
- 1-year return vs S&P 500Bottom 11%
- Distance from 52-week highBottom 10%
- Trend checklist (0–4)Bottom 13%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 23%
- Consecutive EPS beatsTop 15%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 10%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 41%
- Maximum drawdown, 3 yearsBottom 13%
- Beta vs S&P 500 (lower is better)Bottom 7%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 13.0% | 10.0% | ↓ |
| Gross margin | -587.7% | -129.7% | ↑ |
| Operating margin | -1837.6% | -1090.9% | ↑ |
| FCF margin | -1488.5% | -954.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 10.0% | 13.0% | ↓ | Top 47% |
| Gross margin | -129.7% | -587.7% | ↑ | Bottom 5% |
| Operating margin | -1090.9% | -1837.6% | ↑ | Bottom 11% |
| Net margin | -1030.4% | -1800.9% | ↑ | — |
| Free-cash-flow margin | -954.2% | -1488.5% | ↑ | — |
| Return on invested capital | -86.3% | — | Bottom 13% | |
| Revenue growth, 3-year CAGR | -7.0% | — | Bottom 13% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.3%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 104.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -40.2 pp
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -20.64%
- Shareholder yield
- -20.64%
- Share count change, 1 year
- +8.6%
- Share count change, 3-year CAGR
- +18.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 13, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 5
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +19.7%
- Average 2-day reaction, last 8
- -0.2%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $5.00
- Target vs current price
- +320.2%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 13, 2026 | +25.9% | -5.3% | -3.5% | -19.4% | — |
| May 7, 2026 | +21.2% | -3.6% | +8.7% | +6.2% | -23.1% |
| Mar 5, 2026 | +15.2% | -5.0% | +9.4% | +10.6% | +31.1% |
| Nov 12, 2025 | +16.7% | +0.9% | -16.5% | -15.2% | -27.2% |
| Aug 12, 2025 | +12.5% | +4.7% | +9.4% | +7.6% | +26.9% |
| May 8, 2025 | +0.0% | +3.9% | +7.7% | +43.4% | +176.3% |
| Mar 10, 2025 | +2.5% | -4.3% | -12.9% | -33.8% | -9.5% |
| Nov 6, 2024 | +13.6% | +7.4% | -8.2% | -20.3% | -45.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.24 | -$0.32 | +25.9% | $1.5M |
| May 7, 2026 | -$0.26 | -$0.33 | +21.2% | $2.4M |
| Mar 5, 2026 | -$0.28 | -$0.33 | +15.2% | $3.9M |
| Nov 12, 2025 | -$0.30 | -$0.36 | +16.7% | $2.2M |
| Aug 12, 2025 | -$0.35 | -$0.40 | +12.5% | $2.7M |
| May 8, 2025 | -$0.43 | -$0.43 | +0.0% | $2.4M |
| Mar 10, 2025 | -$0.39 | -$0.40 | +2.5% | $2.1M |
| Nov 6, 2024 | -$0.38 | -$0.44 | +13.6% | $2.0M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 12.10× | — | — | Bottom 27% |
| Free-cash-flow yield | -79.13% | — | — | Bottom 4% |
| Earnings yield | -90.76% | — | — | Bottom 8% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -11.1%
- 200-day average slope (20 days)
- -3.0%
- Distance from 50-day average
- -19.3%
- Distance from 200-day average
- -31.5%
- RSI (14)
- 31.3
- Relative volume
- 1.32×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 50.7%
- Volatility vs own 5-year history
- 0th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.32
- Correlation with S&P 500
- 0.45
- Current drawdown from 1-year high
- -58.1%
- Maximum drawdown, 3 years
- -91.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 7, 2021 | Apr 16, 2025 | -97.6% | 906 days | Not yet recovered |
| Aug 23, 2021 | Aug 30, 2021 | -15.9% | 5 days | 4 days (Sep 3, 2021) |
| Aug 10, 2021 | Aug 12, 2021 | -15.8% | 2 days | 7 days (Aug 23, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $121.0M
- EPS, diluted (TTM)
- -$1.08
- Revenue (TTM)
- $10.0M
- 52-week range
- $1.17 – $3.54
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $9.6M | $13.9M | $34.5M | $10.0M | $11.2M |
| Gross profit | $8.6M | $10.2M | $31.0M | $6.1M | $7.5M |
| Operating income | -$67.0M | -$106.4M | -$116.1M | -$166.6M | -$136.2M |
| Net income | -$66.9M | -$99.4M | -$102.1M | -$149.1M | -$148.1M |
| EPS (diluted) | -$1.11 | -$1.64 | -$1.38 | -$1.65 | -$1.59 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.1M | $2.4M | $2.7M | $2.2M | $3.9M | $2.4M | $1.5M |
| Net income | -$34.7M | -$35.5M | -$40.0M | -$54.1M | -$27.5M | -$26.5M | -$25.1M | -$24.3M |
| EPS (diluted) | -$0.38 | -$0.39 | -$0.43 | -$0.58 | -$0.30 | -$0.28 | -$0.26 | -$0.24 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$32.5M | -$91.0M | -$93.3M | -$138.2M | -$111.0M |
| Capital expenditure | -$3.1M | -$7.1M | -$11.6M | -$6.5M | -$1.4M |
| Free cash flow | -$35.6M | -$98.0M | -$104.9M | -$144.7M | -$112.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $321.0M | $2.1M | $152.7M | $15.2M | $4.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $112.3M
- Total assets
- $142.8M
- Total liabilities
- $44.7M
- Total debt
- $26.7M
- Net debt
- $461,000
- Shareholders’ equity
- $98.1M
As of Jun 30, 2026 (filed Aug 13, 2026).
Short interest
- Shares sold short
- 12,978,605
- Days to cover
- 9.49
- Change vs previous report
- +3.8%
FINRA short interest, settlement date Sep 15, 2026.